In RA FLSs, treatment by siRNA knockdown of SAE1 or UBA2 with GA, an inhibitor of SAE1/UBA2-mediated SUMOylation, resulted in reduced glycolysis, inflammatory and aggressive phenotype (123). This evidence concerns the gene UBA2 and rheumatoid arthritis.